Evidence map›Paper›PMID 28082356›Full record

ArticleThe Journal of experimental medicine2017

IKKα controls ATG16L1 degradation to prevent ER stress during inflammation.

Michaela A Diamanti, Jalaj Gupta, Moritz Bennecke, Tiago De Oliveira, Mallika Ramakrishnan, Anne K Braczynski, Benjamin Richter, Petra Beli, Yinling Hu, Maya Saleh and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 63 citations in OpenAlex.

  1. Autophagy modulation in cancer.Nature reviews. Drug discovery · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. ZDHHC7-mediatedAutophagy · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Crohn's disease.Nature reviews. Disease primers · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Michaela A DiamantiInstitute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt am Main, Germany.ORCID 0000-0003-1971-4225
Jalaj GuptaInstitute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt am Main, Germany.ORCID 0000-0002-0153-080X
Moritz BenneckeInstitute of Molecular Immunology, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany.ORCID 0000-0002-3896-4345
Tiago De OliveiraInstitute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt am Main, Germany.ORCID 0000-0002-2502-7897
Mallika RamakrishnanInstitute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt am Main, Germany.ORCID 0000-0003-3144-2824
Anne K BraczynskiEdinger Institute (Institute of Neurology), Goethe University Hospital, Goethe University, 60323 Frankfurt, Germany.
Benjamin RichterInstitute of Biochemistry II, Buchmann Institute for Molecular Life Sciences, Goethe University School of Medicine, Goethe University, 60323 Frankfurt, Germany.ORCID 0000-0002-4872-8637
Petra BeliInstitute of Molecular Biology, 55128 Mainz, Germany.ORCID 0000-0001-9507-9820
Yinling HuCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702.
Maya SalehDepartment of Biochemistry, McGill University, Montreal, Quebec H3G 1Y6, Canada.
Michel MittelbronnEdinger Institute (Institute of Neurology), Goethe University Hospital, Goethe University, 60323 Frankfurt, Germany.
Ivan DikicInstitute of Biochemistry II, Buchmann Institute for Molecular Life Sciences, Goethe University School of Medicine, Goethe University, 60323 Frankfurt, Germany.ORCID 0000-0001-8156-9511
Florian R GretenInstitute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt am Main, Germany greten@gsh.uni-frankfurt.de.ORCID 0000-0002-3928-6080
Georg Speyer Haus · DEGoethe University Frankfurt · DEInstitute of Molecular Biology · DEMcGill University · CANational Cancer Institute · USTUM Klinikum · DE

Funding

Role of IKKalpha in lymphoid organ developmentZIABC011422 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HU, YINLING · 2012 to 2025
$4.4M
6 · The paper itself

Abstract

Inhibition of the IκB kinase complex (IKK) has been implicated in the therapy of several chronic inflammatory diseases including inflammatory bowel diseases. In this study, using mice with an inactivatable IKKα kinase (Ikkα

Indexed as

AnimalsAutophagy-Related ProteinsCarrier ProteinsCaspase 12ColitisEndoplasmic Reticulum StressEndoribonucleasesI-kappa B KinaseInflammationInterleukin-18MiceNF-kappa BNod2 Signaling Adaptor ProteinProtein Serine-Threonine KinasesProtein StabilityUnfolded Protein ResponseAtg16l1 protein, mouseAutophagy-Related ProteinsCarrier ProteinsCaspase 12EndoribonucleasesErn1 protein, mouseI-kappa B KinaseInterleukin-18NF-kappa BNod2 protein, mouseNod2 Signaling Adaptor ProteinProtein Serine-Threonine Kinases

Identifiers

PMID28082356
PMCPMC5294863
OpenAlexW2576779894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.